Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Studies genetic changes in people with lung cancer

Looks at gene and immune changes in people with lung cancer.

Plain-language title generated from the registry record
Registry title: Detection of Genetic Markers of Lung Cancer

Key facts

Where
Pittsburgh, United StatesSee the site

Where in United States

  • Hillman Cancer CenterPittsburgh, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Pittsburgh
Trial code
NCT00280202
Record updated
10 November 2026
Original description
The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.Read full original descriptionShow less

Detection of Genetic Markers of Lung Cancer Initiation and Progression

The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.

Inclusion: Histologic confirmation of lung cancer, lung metastases from a primary site other than lung, mesothelioma or a radiographic lesion highly suspicious for malignancy; Written informed consent; To be scheduled for a biopsy or surgical resection or have already had a biopsy and/or surgical removal of a lung mass.

Exclusion: None.

ClinicalTrials.gov NCT00280202